When modelling carriage of KRAS and/or GNAS mutational status (excluding cases with acellular peritoneal mucin), genetic variation in these genes significantly contributed to hazard (p = 0.004, HR = 1.87) compared to cases with no mutation in either gene after accounting for CC scoring and peritoneal disease grade (Figure 4B). This evidence concerns the gene GNAS and disease of peritoneum.